Published on: May 1, 2026
ELIMINATION OF CERVICAL CANCER
ELIMINATION OF CERVICAL CANCER
CONTEXT: In 2018, the World Health Organization launched a global initiative to eliminate cervical cancer, formally adopted in 2020 by 194 countries including India.
Cervical Cancer: Disease Burden and Impact
Extent of the Problem
- Cervical cancer is the second most common cancer among women in India.
- Around 1 lakh new cases annually and ~50,000 deaths, accounting for one-fourth of global burden.
- Affects relatively younger women, causing high years of life lost.
Health and Social Impact
- Causes severe physical suffering, including pain, bleeding, and organ complications.
- Leads to emotional distress and financial hardship for families.
- Advanced stages may cause renal failure, fistulas, and chronic pain
Prevention and Early Detection
Secondary Prevention (Screening)
- Since the 1940s, Pap smear screening helps detect precancerous stages.
- Cervical cancer has a long precancerous phase (10–15 years) called Cervical Intraepithelial Neoplasia (CIN).
- Early detection allows simple and effective treatment without major surgery.
Challenges in India
- Lack of infrastructure and trained manpower limits screening.
- Screening coverage remains below 5%.
- Poor follow-up and treatment compliance among women.
- Outreach programs are insufficient compared to population needs.
HPV Vaccine: A Game Changer
Introduction of Vaccine
- HPV vaccine introduced in 2006 for primary prevention.
- Initially required three doses, now effective with single dose.
- Provides 85–90% protection against cervical cancer.
- Targets major strains HPV 16 and 18, responsible for most cases.
- Over 500 million doses globally, ~4 million in India.
- No serious side effects; only mild and temporary reactions.
- No impact on fertility, reproduction, or menstrual health.
Global Success Examples
- Countries like Australia, UK, Sweden, Denmark, Canada, USA show decline in cancer and pre-cancer cases.
Global Strategy for Elimination
WHO Targets (By 2030)
- 90% of girls vaccinated before age 15.
- 70% of women screened at ages 35 and 45.
- 90% of detected cases treated.
Goal
- Reduce incidence to less than 4 cases per 1,00,000 women.
India’s Efforts and Initiatives National HPV Vaccination Campaign (2026)
- Launched on February 28, 2026.
- Focus on free vaccination for adolescent girls (~14 years).
- Demonstrates strong political commitment to women’s health.
Significance
- Promotes preventive healthcare and awareness.
- Aims to achieve cervical cancer-free India by 2047 (Viksit Bharat).
Key Challenges
- Low awareness among parents and communities.
- Limited screening coverage and healthcare access.
- Weak last-mile delivery and follow-up systems.
Way Forward
- Increase awareness about HPV vaccination and screening.
- Strengthen health infrastructure and outreach programs.
- Ensure universal access to vaccines and early diagnosis.
- Improve compliance and monitoring systems.
Conclusion
- Cervical cancer is largely preventable and treatable if detected early.
- HPV vaccination + screening form the backbone of elimination strategy.
- With strong implementation, India can achieve significant reduction in disease burden
